Cancer-associated cachexia is defined by loss of weight and muscle mass, and by the potential loss of adipose tissue accompanied by insulin resistance and increased resting energy expenditure. Cachexia is most prevalent in pancreatic cancer, the third leading cause of cancer-related deaths. While various factors interact to induce cachexia, the precise mechanisms underlying this clinical condition are not fully understood. Clinically relevant animal models of cachexia are needed given the lack of standard diagnostic methods or treatments for this condition. Described in this article are in vitro and in vivo models used to study the role of macrophages in the induction of cachexia in pancreatic cancer. Included are procedures for isolating and culturing bone marrow-derived macrophages, harvesting tumor- and macrophage-derived conditioned medium, and studying the effect of conditioned medium on C2C12 myotubes. Also described are procedures involving the use of an orthotopic model of pancreatic cancer, including a method for examining skeletal muscle atrophy in this model.
Cancer-associated cachexia is defined by loss of weight and muscle mass, and by the potential loss of adipose tissue accompanied by insulin resistance and increased resting energy expenditure. Cachexia is most prevalent in pancreatic cancer, the third leading cause of cancer-related deaths. While various factors interact to induce cachexia, the precise mechanisms underlying this clinical condition are not fully understood. Clinically relevant animal models of cachexia are needed given the lack of standard diagnostic methods or treatments for this condition. Described in this article are in vitro and in vivo models used to study the role of macrophages in the induction of cachexia in pancreatic cancer. Included are procedures for isolating and culturing bone marrow-derived macrophages, harvesting tumor- and macrophage-derived conditioned medium, and studying the effect of conditioned medium on C2C12 myotubes. Also described are procedures involving the use of an orthotopic model of pancreatic cancer, including a method for examining skeletal muscle atrophy in this model.
Authors: Claudia Galuschka; Rumyana Proynova; Benjamin Roth; Hellmut G Augustin; Karin Müller-Decker Journal: Cancer Res Date: 2017-05-15 Impact factor: 12.701
Authors: Surendra K Shukla; Spas D Markov; Kuldeep S Attri; Enza Vernucci; Ryan J King; Aneesha Dasgupta; Paul M Grandgenett; Michael A Hollingsworth; Pankaj K Singh; Fang Yu; Kamiya Mehla Journal: Cancer Lett Date: 2020-04-25 Impact factor: 8.679
Authors: S C Bodine; E Latres; S Baumhueter; V K Lai; L Nunez; B A Clarke; W T Poueymirou; F J Panaro; E Na; K Dharmarajan; Z Q Pan; D M Valenzuela; T M DeChiara; T N Stitt; G D Yancopoulos; D J Glass Journal: Science Date: 2001-10-25 Impact factor: 47.728
Authors: Katherine A Michaelis; Xinxia Zhu; Kevin G Burfeind; Stephanie M Krasnow; Peter R Levasseur; Terry K Morgan; Daniel L Marks Journal: J Cachexia Sarcopenia Muscle Date: 2017-07-20 Impact factor: 12.910
Authors: Aneesha Dasgupta; Surendra K Shukla; Enza Vernucci; Ryan J King; Jaime Abrego; Scott E Mulder; Nicholas J Mullen; Gavin Graves; Kyla Buettner; Ravi Thakur; Divya Murthy; Kuldeep S Attri; Dezhen Wang; Nina V Chaika; Camila G Pacheco; Ibha Rai; Dannielle D Engle; Paul M Grandgenett; Michael Punsoni; Bradley N Reames; Melissa Teoh-Fitzgerald; Rebecca Oberley-Deegan; Fang Yu; Kelsey A Klute; Michael A Hollingsworth; Matthew C Zimmerman; Kamiya Mehla; Junichi Sadoshima; David A Tuveson; Pankaj K Singh Journal: J Exp Med Date: 2020-07-06 Impact factor: 14.307